According to the offering prospectus, of the 11'524'805 registered shares shown in the Commercial Register, 4,380,000, or 38% of the company's outstanding stock, were offered to the public. Should the underwriters elect to exercise their green-shoe option, that proportion could rise to 42%.
Oridion Systems Ltd. with its headquarter in Jerusalem (Israel), is a Life Science company aiming to develope and produce medical technology equipment and disposable materials for use in capnography, the measurement of the carbon dioxide.
Oridion Systems Ltd. founded in employs 109 individuals and recorded in 1999 revenues of USD six million and a gross profit of USD 1.9 million. The company maintains subsidiaries in USA, Spain and Israel.
